Streptococcus pneumoniae–a review of carriage, infection, serotype replacement and vaccination
Invasive pneumococcal infection remains a leading global cause of morbidity and mortality
in young children. In developed nations, a substantial decrease in the incidence of IPD has …
in young children. In developed nations, a substantial decrease in the incidence of IPD has …
10-valent pneumococcal nontypeable Haemophilus influenzae PD conjugate vaccine: Synflorix™
R Prymula, L Schuerman - Expert review of vaccines, 2009 - Taylor & Francis
The global burden of disease due to Streptococcus pneumoniae remains high. The licensed
7-valent pneumococcal conjugate vaccine (7vCRM, Prevenar™/Prevnar™) has successfully …
7-valent pneumococcal conjugate vaccine (7vCRM, Prevenar™/Prevnar™) has successfully …
Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: a cluster …
AA Palmu, J Jokinen, D Borys, H Nieminen… - The Lancet, 2013 - thelancet.com
Summary Background The Finnish Invasive Pneumococcal disease (FinIP) vaccine trial was
designed to assess the effectiveness of a pneumococcal vaccine containing ten serotype …
designed to assess the effectiveness of a pneumococcal vaccine containing ten serotype …
[HTML][HTML] A phase 3, multicenter, randomized, double-blind, active-comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of a 4-dose …
Background Pneumococcal disease (PD) remains a major health concern with considerable
morbidity and mortality in children. Currently licensed pneumococcal conjugate vaccines …
morbidity and mortality in children. Currently licensed pneumococcal conjugate vaccines …
Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM …
T Vesikari, J Wysocki, B Chevallier… - The Pediatric …, 2009 - journals.lww.com
Background: The immunogenicity of the 10-valent pneumococcal nontypeable Haemophilus
influenzae protein D-conjugate vaccine (PHiD-CV) was assessed and compared with the 7 …
influenzae protein D-conjugate vaccine (PHiD-CV) was assessed and compared with the 7 …
The relationship between pneumococcal serotypes and antibiotic resistance
JH Song, R Dagan, KP Klugman, B Fritzell - Vaccine, 2012 - Elsevier
Streptococcus pneumoniae (SP) causes significant burden of disease, including invasive
pneumococcal disease and noninvasive diseases such as pneumonia and acute otitis …
pneumococcal disease and noninvasive diseases such as pneumonia and acute otitis …
Impact of the Conjugation Method on the Immunogenicity of Streptococcus pneumoniae Serotype 19F Polysaccharide in Conjugate Vaccines
J Poolman, C Frasch, A Nurkka… - Clinical and Vaccine …, 2011 - Am Soc Microbiol
ABSTRACT 7vCRM (Pfizer, Inc.) and PHiD-CV (GlaxoSmithKline Biologicals) are two
pneumococcal conjugate vaccines licensed for the prevention of invasive pneumococcal …
pneumococcal conjugate vaccines licensed for the prevention of invasive pneumococcal …
Effectiveness of the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D–Conjugated Vaccine (PHiD-CV) Against Carriage and …
T Vesikari, A Forsten, I Seppä… - Journal of the …, 2016 - academic.oup.com
After administering the 10-valent pneumococcal polysaccharide nontypeable Haemophilus
influenzae protein D–conjugated vaccine (PHiD-CV) to children aged 2–18 months, we …
influenzae protein D–conjugated vaccine (PHiD-CV) to children aged 2–18 months, we …
The 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) coadministered with DTPw-HBV/Hib and poliovirus …
N Bermal, L Szenborn, A Chrobot… - The Pediatric …, 2009 - journals.lww.com
Background: Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus
influenzae protein D-conjugate vaccine (PHiD-CV) was evaluated when coadministered …
influenzae protein D-conjugate vaccine (PHiD-CV) was evaluated when coadministered …
Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different …
J Wysocki, JC Tejedor, D Grunert… - The Pediatric …, 2009 - journals.lww.com
Background: Immunogenicity of the candidate 10-valent pneumococcal non-typeable
Haemophilus influenzae protein D-conjugate vaccine (PHiD-CV) was assessed when …
Haemophilus influenzae protein D-conjugate vaccine (PHiD-CV) was assessed when …